PubMed Summary

Title Average Ratingsort descending
Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age. 0.00%
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer........ 0.00%
Effect of Ukrain on human liver alcohol dehydrogenase activity in vitro. 0.00%
Teratological evaluation of Ukrain in hamsters and rats 0.00%
Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) stud 0.00%
Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment. 0.00%
Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort s 0.00%
Preliminary pharmacokinetic studies of Ukrain in rats 0.00%
The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhib 0.00%
Six-week treatment with Ukrain in rabbits. Part III: Serum levels of thyroid hormones 0.00%
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative.... 0.00%
Removed because of suspicion of scientific fraud: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF. 10.00%
Six-week treatment with Ukrain in rabbits. Part II: Serum levels of gonadal hormones 20.00%
Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer. 20.00%
Ukrain therapy of a recurrent astrocytoma of the optic nerve (case report) 20.00%
Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain. 20.00%
Targeting GIPC/synectin in pancreatic cancer inhibits tumor growth. 30.00%
Management of the patient and family with neurofibromatosis 2: a consensus conference statement. 30.00%
Effect of Ukrain on the efficacy of anti-epileptic drugs against maximal electroshock-induced seizures in mice. 30.00%
The influence of Ukrain on the growth of HA-1 tumor in mice: the role of cysteine proteinases as markers of tumor malignancy 30.00%
Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice. 30.00%
A retrospective analysis of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation therapy followe 30.00%
Ukrain treatment of a patient with retroperitoneal synovial sarcoma. 35.00%
Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor. 40.00%
Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts. 40.00%
Ependymoma. 40.00%
Ukrain therapy in a frontal anaplastic grade III astrocytoma (case report) 40.00%
Ukrain treatment of rhabdomyosarcoma (case report) 40.00%
Inhibition of MIF Leads to Cell Cycle Arrest and Apoptosis in Pancreatic Cancer Cells. 40.00%
Ukrain: acute toxicity after intravenous, intramuscular and oral administration in rats 40.00%
Pancreatic cancer stem cells - insights and perspectives. 40.00%
In vitro and in vivo antiproliferative activity of laherradurin and cherimolin-2 of Annona diversifolia Saff. 40.00%
Enhancement of macrophage tumouricidal activity by the alkaloid derivative 40.00%
Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic 40.00%
Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancer. 40.00%
Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor. 40.00%
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer. 40.00%
Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer. 40.00%
Long term outcomes following surgical resection of myxopapillary ependymomas. 40.00%
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplat 40.00%
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal 50.00%
Ukrain treatment in a patient with metastatic renal cell carcinoma extending to the vena cava inferior. 50.00%
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer. 50.00%
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer 50.00%
Do Recurrent and Metastatic Pancreatic Cancer Patients Have the Same Outcomes with Gemcitabine Treatment? 50.00%
Annonacin, a mono-tetrahydrofuran acetogenin, arrests cancer cells at the G1 phase and causes cytotoxicity in a Bax- and caspase 50.00%
A study of the influence of a novel drug Ukrain on in vivo effects of low-dose ionizing radiation 50.00%
Six-week treatment with Ukrain in rabbits. Part I: Morphological parameters 50.00%
Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line 50.00%
Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, 50.00%
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer 50.00%
Five novel mono-tetrahydrofuran ring acetogenins from the seeds of Annona muricata. 50.00%
Ukrain (NSC-631570) influences on bone status: a review. 50.00%
Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer. 50.00%
A method for determination of Ukrain in blood plasma for monitoring and pharmacokinetic study 50.00%
Morphometric and kinetic analysis of the growth of experimental sarcoma-45 in the presence of Ukrain 50.00%
Ukrain in the treatment of urethral recurrent carcinoma (case report) 50.00%
Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus u 50.00%
Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. 50.00%
Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model. 50.00%
Effect of alkaloid sanguinarine and a pharmaceutical preparation ukrain on modulation of vesicular membrane fusion and actin.... 50.00%
A Phase I study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers. 50.00%
Comparative in vitro study of the effects of the new antitumor drug Ukrain and several cytostatic agents on the thiol groups in 50.00%
Ukrain with chemotherapy in malignant melanoma (case report) 50.00%
Roles of sildenafil in enhancing drug sensitivity in cancer. 50.00%
The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary 50.00%
Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. 50.00%
Case report of a pituitary macroadenoma treated with artemether. 50.00%
Influence of Ukrain on the nuclear thyroid hormone receptors after short-term gamma-irradiation. 50.00%
Ukrain treatment in a patient with non-seminomatous germ-cell tumour of testis (case report) 50.00%
Biological activity of some thiophosphamide derivatives of alkaloids with respect to influenza virus 50.00%
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities 50.00%
A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin.... 50.00%
Inhibition of angiogenesis by non-toxic doses of temozolomide. 50.00%
WITHDRAWN: Ovarian ablation for early breast cancer. 50.00%
Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer. 50.00%
Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy. 50.00%
Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomide. 50.00%
Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and 50.00%
Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured gliobl 50.00%
Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryother 50.00%
Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors. 50.00%
Chemoradiotherapy in malignant glioma: standard of care and future directions. 50.00%
Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-Km catalysts of cyclophosp 50.00%
Chemoradiotherapy with twice-weekly administration of low-dose gemcitabine for locally advanced pancreatic cancer. 50.00%
Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer. 50.00%
Inhibition of angiogenesis of LCI-D20 hepatocellular carcinoma by metronomic chemotherapy of S-1 50.00%
Results of Ukrain monotherapy of prostate cancer 50.00%
Tumoral angiogenesis: review of the literature. 50.00%
Propolis Extract (Bio 30) Suppresses the Growth of Human Neurofibromatosis (NF) Tumor Xenografts in Mice 55.00%
Removed from Pubmed because of suspicion of scientific fraud: Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). 55.00%
Alert because of Scientific Fraud: Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF). 55.00%
Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid 55.00%
Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glyc 60.00%
Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer. 60.00%
The effects of thiophosphoric acid (Ukrain) on cervical cancer, stage IB bulky 60.00%
Tolerance to the anticonvulsant effect of morphine in mice: blockage by ultra-low dose naltrexone. 60.00%
Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of 60.00%
Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study. 60.00%
1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising.. 60.00%

Pages